AVITA Medical (RCEL) CFO David O'Toole Buys Stock

What Happened David D. O'Toole, Chief Financial Officer of AVITA Medical, reported a purchase of 1,800 shares on 2026-03-11 at $4.78 per share, for a total reported cost of $8,604. The Form 4 records this as a purchase (code P), described as an open-market or private purchase.

Key Details

• Transaction date and price: 2026-03-11 — 1,800 shares at $4.78 each.
• Total value: $8,604.
• Transaction type: Purchase (Form 4 code P) — listed as open-market or private purchase.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: F1 indicates reported holdings include unvested restricted stock units (RSUs).
• Filing timeliness: Reported and filed on 2026-03-11 (no late filing indicated).

Context This was a straightforward buy by a company executive; purchases can be interpreted by some investors as a positive signal, but they do not by themselves explain the insider's motivations. The filing notes that reported ownership includes unvested RSUs, which are restricted awards that may vest over time.